Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma: A Phase Ib Study

Trial Profile

Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma: A Phase Ib Study

Recruiting
Phase of Trial: Phase I

Latest Information Update: 12 Jun 2018

At a glance

  • Drugs TG 02 (Primary) ; Temozolomide
  • Indications Anaplastic astrocytoma; Glioblastoma
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms STEAM
  • Most Recent Events

    • 07 Jun 2018 Status changed from not yet recruiting to recruiting.
    • 16 Feb 2018 Planned End Date changed from 1 Jun 2020 to 1 Aug 2020.
    • 16 Feb 2018 Planned primary completion date changed from 1 Jun 2020 to 1 Aug 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top